Outcome of Primary Tumor in Patients With Synchronous Stage IV Colorectal Cancer Receiving Combination Chemotherapy Without Surgery As Initial Treatment
George A. Poultsides(Stanford University), Phillip Paty(Memorial Sloan Kettering Cancer Center), José G. Guillem(University of North Carolina at Chapel Hill), Leonard B. Saltz(Memorial Sloan Kettering Cancer Center), Nancy E. Kemeny(Memorial Sloan Kettering Cancer Center), Sujata Patil(Dr. D. Y. Patil Medical College, Hospital and Research Centre), W. Douglas Wong(Memorial Sloan Kettering Cancer Center), Martin R. Weiser(Memorial Sloan Kettering Cancer Center), Larissa K. Temple(University of Rochester Medical Center), Elliot L. Servais(Memorial Sloan Kettering Cancer Center)
Cited by 390
Related Papers
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer
|New England Journal of Medicine|2000|3k
OncoKB: A Precision Oncology Knowledge Base
|JCO Precision Oncology|2017|2.7k
Definition and grading of anastomotic leakage following anterior resection of the rectum: A proposal by the International Study Group of Rectal Cancer
|Surgery|2009|1.5k
Cetuximab Shows Activity in Colorectal Cancer Patients With Tumors That Do Not Express the Epidermal Growth Factor Receptor by Immunohistochemistry
|Journal of Clinical Oncology|2005|1.1k